English
Chinese
English
French
German
Mongolian
Portuguese
Russian
Spanish
Chinese
French
German
Mongolian
Portuguese
Russian
Spanish
Frequently asked questions
User Guidelines
Survey
Login
About elearnSCI.org
About elearnSCI.org
About the Society behind the project
International Spinal Cord Society (ISCoS)
About the collaborating partners
About the funding organizations
Principle funding organization
Other funding organizations
About the Core Committee
About the Committees
About the Committees
ElearnSCI.org Editorial Committee
ISCoS Executive Committee
ISCoS Education Committee
ISCoS Scientific Committee
Consumer Advisory Committee
ISIC Editorial Committee
About the company developing the web platform
About the subcommittees and subcommittee coordinators
Secretarial and other support
Acknowledgement of translators
Messages
President ISCoS
Chief Coordinator and Editor
Chairperson of Education Committee
Chairperson Scientific Committee
Collaborating Partners
Collaborating Partners
ISIC
Livability
ASCoN
Principal sponsor – Access to Health Care
Past President ISCoS
Modules
Modules
Overview for the Whole Team
Doctors
Nurses
Occupational Therapists & Assistive Technologists
Physiotherapists
Prevention
Psychologists, Social Workers and Peer Counsellors
Consumer
Terms
Glossary
Abbreviation
Contact Us
Cell transplant therapy
Butler MG, Menitove JE. Umbilical cord blood banking: an update.
Journal of assisted reproduction and genetics
2011;
28:
669-676.
Chhabra HS, Lima C, Sachdeva S, Mittal A, Nigam V, Chaturvedi D
et al.
Autologous olfactory [corrected] mucosal transplant in chronic spinal cord injury: an Indian Pilot Study.
Spinal cord
2009;
47:
887-895.
Fawcett JW, Curt A, Steeves JD, Coleman WP, Tuszynski MH, Lammertse D
et al.
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials.
Spinal cord
2007;
45:
190-205.
Heinemann AW, Steeves JD, Boninger M, Groah S, Sherwood AM. State of the Science in Spinal Cord Injury Rehabilitation 2011: informing a new research agenda.
Spinal cord
2012;
50:
390-397.
Illes J, Reimer JC, Kwon BK. Stem cell clinical trials for spinal cord injury: readiness, reluctance, redefinition.
Stem cell reviews
2011;
7:
997-1005.
Kwon BK, Okon EB, Plunet W, Baptiste D, Fouad K, Hillyer J
et al.
A systematic review of directly applied biologic therapies for acute spinal cord injury.
Journal of neurotrauma
2011;
28:
1589-1610.
Lammertse D, Tuszynski MH, Steeves JD, Curt A, Fawcett JW, Rask C
et al.
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design.
Spinal cord
2007;
45:
232-242.
Lammertse DP, Jones LAT, Charlifue SB, Kirshblum SC, Apple DF, Ragnarsson KT
et al.
Autologous incubated macrophage therapy in acute, complete spinal cord injury: results of the phase 2 randomized controlled multicenter trial.
Spinal cord
2012.
Mackay-Sim A, Féron F, Cochrane J, Bassingthwaighte L, Bayliss C, Davies W
et al.
Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial.
Brain: a journal of neurology
2008;
131:
2376-2386.
Nakamura M, Tsuji O, Nori S, Toyama Y, Okano H. Cell transplantation for spinal cord injury focusing on iPSCs.
Expert opinion on biological therapy
2012;
12:
811-821.
Noble M, Mayer-Pröschel M, Davies JE, Davies SJA, Pröschel C. Cell therapies for the central nervous system: how do we identify the best candidates?
Current opinion in neurology
2011;
24:
570-576.
Nori S, Okada Y, Yasuda A, Tsuji O, Takahashi Y, Kobayashi Y
et al.
Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice.
Proceedings of the National Academy of Sciences of the United States of America
2011;
108:
16825-16830.
Oliveri RS. Epigenetic dedifferentiation of somatic cells into pluripotency: cellular alchemy in the age of regenerative medicine?
Regenerative medicine
2007;
2:
795-816.
Parke S, Illes J. In delicate balance: stem cells and spinal cord injury advocacy.
Stem cell reviews
2011;
7:
657-663.
Pluchino S, Cusimano M, Bacigaluppi M, Martino G. Remodelling the injured CNS through the establishment of atypical ectopic perivascular neural stem cell niches.
Archives italiennes de biologie
2010;
148:
173-183.
Ruff CA, Wilcox JT, Fehlings MG. Cell-based transplantation strategies to promote plasticity following spinal cord injury.
Experimental neurology
2012;
235:
78-90.
Salewski RPF, Eftekharpour E, Fehlings MG. Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury?
Journal of cellular physiology
2010;
222:
515-521.
Steeves JD, Lammertse D, Curt A, Fawcett JW, Tuszynski MH, Ditunno JF
et al.
Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures.
Spinal cord
2007;
45:
206-221.
Steeves JD, Zariffa J, Kramer JLK. Are you "tilting at windmills" or undertaking a valid clinical trial?
Yonsei medical journal
2011;
52:
701-716.
Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, Hill CE, Sparling JS, Plemel JR
et al.
A systematic review of cellular transplantation therapies for spinal cord injury.
Journal of neurotrauma
2011;
28:
1611-1682.
Thomas KE, Moon LDF. Will stem cell therapies be safe and effective for treating spinal cord injuries?
British medical bulletin
2011;
98:
127-142.
Thuret S, Moon LDF, Gage FH. Therapeutic interventions after spinal cord injury.
Nature reviews. Neuroscience
2006;
7:
628-643.
Tuszynski MH, Steeves JD, Fawcett JW, Lammertse D, Kalichman M, Rask C
et al.
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics.
Spinal cord
2007;
45:
222-231.
Yoon SH, Shim YS, Park YH, Chung JK, Nam JH, Kim MO, et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial.
Stem Cells
. 2007;
25
:2066-73.
An initiative of
Collaborating Partners
Principal sponsor